BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE; NALOXONE HY) — FDA Approval ANDA205954 (ALVOG
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE; NALOXONE HY) — FDA Approval ANDA205954 (ALVOG is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE; Active ingredients: BUPRENORPHINE HYDROCHLORID
| Brand name | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE |
|---|---|
| Active ingredients | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
| Application number | ANDA205954 |
| Sponsor | ALVOGEN |
| Dosage form | FILM |
| Route | BUCCAL, SUBLINGUAL |
| Marketing status | Prescription |
| Products in application | 4 |
| First approval date | 20190124 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →